Literature DB >> 8557995

Extracellular matrix proteins attenuate activation and degranulation of stimulated eosinophils.

H Kita1, S Horie, G J Gleich.   

Abstract

Cellular adhesion plays an important role in the recruitment and activation of eosinophils. Here, we investigated whether extracellular matrix (ECM) proteins modify effector functions of activated human eosinophils. We coated 96-well plates with laminin or fibronectin and blocked nonspecific protein-binding sites with human serum albumin (HSA). When eosinophils were stimulated with platelet-activating factor (PAF) and incubated in these ECM-coated wells, the eosinophils adhered using both beta 1- and beta 2-integrins. Degranulation of eosinophils adherent to laminin- and fibronectin-coated wells was reduced about 50% compared with cells adherent to uncoated, HSA-blocked wells. Furthermore, these inhibitory effects of laminin and fibronectin were concentration-dependent and secretagogue-specific, that is, degranulation induced by C5a and IL-5 was inhibited while degranulation induced by secretory IgA and PMA was not inhibited. Plasma fibronectin, type I collagen and type IV collagen also inhibited PAF- and C5a-induced eosinophil degranulation, whereas fibrinogen did not. By microscopy, PAF-stimulated eosinophils, adhering to uncoated HSA-blocked wells, appeared elongated with many pseudopods. In contrast, eosinophils adhering to laminin-coated wells appeared oval with few pseudopods. Furthermore, when cells were incubated in laminin-coated wells, PAF-stimulated production of a second messenger, inositol phosphate, was markedly reduced. These findings suggest that ECM protein, such as laminin and fibronectin, attenuate both activation and degranulation of eosinophils and also influence their morphology after stimulation by physiologic secretagogues. Thus, ECM proteins may regulate activation of eosinophils, as they traverse between the peripheral blood and their targets.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557995

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).

Authors:  Paneez Khoury; Praveen Akuthota; Steven J Ackerman; Joseph R Arron; Bruce S Bochner; Margaret H Collins; Jean-Emmanuel Kahn; Patricia C Fulkerson; Gerald J Gleich; Rashmi Gopal-Srivastava; Elizabeth A Jacobsen; Kristen M Leiferman; Levi-Schaffer Francesca; Sameer K Mathur; Michael Minnicozzi; Calman Prussin; Marc E Rothenberg; Florence Roufosse; Kathleen Sable; Dagmar Simon; Hans-Uwe Simon; Lisa A Spencer; Jonathan Steinfeld; Andrew J Wardlaw; Michael E Wechsler; Peter F Weller; Amy D Klion
Journal:  J Leukoc Biol       Date:  2018-04-19       Impact factor: 4.962

Review 2.  Regulation of the Immune System by Laminins.

Authors:  Thomas Simon; Jonathan S Bromberg
Journal:  Trends Immunol       Date:  2017-07-03       Impact factor: 16.687

3.  Asthmatic Eosinophils Alter the Gene Expression of Extracellular Matrix Proteins in Airway Smooth Muscle Cells and Pulmonary Fibroblasts.

Authors:  Ieva Janulaityte; Andrius Januskevicius; Airidas Rimkunas; Jolita Palacionyte; Astra Vitkauskiene; Kestutis Malakauskas
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

4.  Human eosinophil-airway smooth muscle cell interactions.

Authors:  J M Hughes; C A Arthur; S Baracho; S M Carlin; K M Hawker; P R Johnson; C L Armour
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

5.  Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge.

Authors:  T R Johnson; J E Johnson; S R Roberts; G W Wertz; R A Parker; B S Graham
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.